Patents by Inventor Fabrizio Samaritani

Fabrizio Samaritani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LIQUID FORMULATIONS OF TUMOR NECROSIS FACTOR-BINDING PROTEINS
    Publication number: 20170020960
    Abstract: The invention relates to a stable, pharmaceutically acceptable, aqueous formulation of TNF-binding protein, comprising a TNF-binding protein, a buffer and an isotonicity agent.
    Type: Application
    Filed: September 30, 2016
    Publication date: January 26, 2017
    Applicant: ARES TRADING S.A.
    Inventors: FABRIZIO SAMARITANI, ALESSANDRA DEL RIO, RITA AGOSTINETTO
  • Liquid formulations of tumor necrosis factor-binding proteins
    Patent number: 9512215
    Abstract: The invention relates to a stable, pharmaceutically acceptable, aqueous formulation of TNF-binding protein, comprising a TNF-binding protein, a buffer and an isotonicity agent.
    Type: Grant
    Filed: December 15, 2014
    Date of Patent: December 6, 2016
    Assignee: ARES TRADING S.A.
    Inventors: Fabrizio Samaritani, Alessandra Del Rio, Rita Agostinetto
  • LIQUID FORMULATIONS OF TUMOR NECROSIS FACTOR-BINDING PROTEINS
    Publication number: 20150098950
    Abstract: The invention relates to a stable, pharmaceutically acceptable, aqueous formulation of TNF-binding protein, comprising a TNF-binding protein, a buffer and an isotonicity agent.
    Type: Application
    Filed: December 15, 2014
    Publication date: April 9, 2015
    Applicant: ARES TRADING S.A.
    Inventors: Fabrizio Samaritani, Alessandra Del Rio, Rita Agostinetto
  • Liquid formulations of tumor necrosis factor-binding proteins
    Patent number: 8937045
    Abstract: The invention relates to a stable, pharmaceutically acceptable, aqueous formulation of TNF-binding protein, comprising a TNF-binding protein, a buffer and an isotonicity agent.
    Type: Grant
    Filed: February 11, 2004
    Date of Patent: January 20, 2015
    Assignee: Ares Trading S.A.
    Inventors: Fabrizio Samaritani, Alessandra Del Rio, Rita Agostinetto
  • LH liquid formulations
    Patent number: 8664369
    Abstract: The invention relates to liquid pharmaceutical formulations of luteinizing hormone (LH) for single- or multi-dose administration.
    Type: Grant
    Filed: October 29, 2008
    Date of Patent: March 4, 2014
    Assignee: Merck Serono S.A.
    Inventors: Rita Agostinetto, Fabrizio Samaritani, Alessandra Del Rio, Joel Richard
  • GRF-containing lyophilized pharmaceutical compositions
    Patent number: 8431534
    Abstract: Human growth hormone factor (GFR) containing pharmaceutical compositions are described, and more precisely, lyophilized compositions of hGRF stabilized by means of saccharose.
    Type: Grant
    Filed: May 3, 2007
    Date of Patent: April 30, 2013
    Assignee: Merck Serono SA
    Inventors: Fabrizio Samaritani, Alessandra Del Rio
  • Human serum albumin-free stabilized interferon liquid formulations
    Patent number: 8309069
    Abstract: A stabilized HSA-free liquid pharmaceutical composition is described, which comprises an interferon (IFN), wherein said formulation is a solution that comprises a buffer, a surfactant, an isotonicity agent and an antioxidant. Preferably the interferon is human recombinant IFN-beta.
    Type: Grant
    Filed: April 29, 2004
    Date of Patent: November 13, 2012
    Assignee: Ares Trading S.A.
    Inventors: Fabrizio Samaritani, Alessandra Del Rio
  • LH LIQUID FORMULATIONS
    Publication number: 20100261649
    Abstract: The invention relates to liquid pharmaceutical formulations of luteinizing hormone (LH) for single- or multi-dose administration.
    Type: Application
    Filed: October 29, 2008
    Publication date: October 14, 2010
    Inventors: Rita Agostinetto, Fabrizio Samaritani, Alessandra Del Rio, Joel Richard
  • Liquid pharmaceutical formulations of FSH and LH together with a non-ionic surfactant
    Patent number: 7741268
    Abstract: The invention relates to the field of pharmaceutical formulations of follicle-stimulating hormone (FSH), luteinising hormone (LH), and mixtures of FSH and luteinising hormone (LH), and to methods of producing such formulations. The invention provides a liquid or freeze-dried formulation of FSH, or LH, or FSH and LH comprising a surfactant selected from Pluronic® F77, Pluronic F87, Pluronic F88 and Pluronic F68.
    Type: Grant
    Filed: April 2, 2004
    Date of Patent: June 22, 2010
    Assignee: Ares Trading S.A.
    Inventors: Fabrizio Samaritani, Piergiorgio Donati
  • Freeze-dried FSH/LH formulations
    Patent number: 7740884
    Abstract: The invention relates to the field of pharmaceutical formulations of a mixture of follicle stimulating hormone (FSH) and luteinising hormone (LH), and to methods of producing such formulations.
    Type: Grant
    Filed: June 16, 2004
    Date of Patent: June 22, 2010
    Assignee: Ares Trading S.A.
    Inventors: Fabrizio Samaritani, Piergiorgio Donati
  • Stabilized interferon liquid formulations
    Patent number: 7731948
    Abstract: A stabilized HSA-free liquid pharmaceutical composition is described, which comprises an interferon (IFN), wherein said formulation is a solution that comprises a buffer, an amino acid and an antioxidant. Preferably, the interferon is human recombinant IFN-beta.
    Type: Grant
    Filed: May 27, 2005
    Date of Patent: June 8, 2010
    Assignee: Ares Trading S.A.
    Inventors: Fabrizio Samaritani, Alessandra Del Rio
  • Stabilized liquid protein formulations in pharmaceutical containers
    Patent number: 7540382
    Abstract: A container comprising a closure means coated by an inert fluorinated material and containing a liquid pharmaceutical composition. In particular, the container comprises a closure means coated by TEFLON (polytetrafluoruethylene (PTFE)) and contains a HSA-free Interferon-? formulation having the following composition: 30 to 100 ?g/ml of interferon-?, an isotonicity agent, 0.1 to 2 mg/ml of Poloxamer 188, at least 0.12 mg/ml of L-Methionine and a buffer solution capable of maintaining the pH of the liquid formulation at a value between 3.0 and 4.0.
    Type: Grant
    Filed: May 12, 2004
    Date of Patent: June 2, 2009
    Assignee: Ares Trading S.A.
    Inventors: Fabrizio Samaritani, Alessandra Del Rio
  • IFN-? liquid formulations
    Patent number: 7407651
    Abstract: Interferon-beta liquid formulations stabilized with a polyol, a non-reducing sugar or a amino acid. In particular, the formulations are stabilized with a polyol, such as mannitol. The formulations, preferably, furthermore comprise a buffer, such as acetate buffer, at a pH comprised between 3.0 and 4.0 and human albumin at a minimum quantity. The interferon-beta is preferably recombinant.
    Type: Grant
    Filed: July 16, 2004
    Date of Patent: August 5, 2008
    Assignee: Applied Research Systems ARS Holding NV
    Inventors: Fabrizio Samaritani, Patrizia Natale
  • Stabilized Interferon Liquid Formulations
    Publication number: 20070292391
    Abstract: A stabilized HSA-free liquid pharmaceutical composition is described, which comprises an interferon (IFN), wherein said formulation is a solution that comprises a buffer, an amino acid and an antioxidant. Preferably, the interferon is human recombinant IFN-beta.
    Type: Application
    Filed: May 27, 2005
    Publication date: December 20, 2007
    Applicant: Ares Trading S.A.
    Inventors: Fabrizio Samaritani, Alessandra Del Rio
  • GRF-CONTAINING LYOPHILIZED PHARMACEUTICAL COMPOSITIONS
    Publication number: 20070203069
    Abstract: Human growth hormone factor (GFR) containing pharmaceutical compositions are described, and more precisely, lyophilized compositions of hGRF stabilized by means of saccharose.
    Type: Application
    Filed: May 3, 2007
    Publication date: August 30, 2007
    Inventors: Fabrizio Samaritani, Alessandra Rio
  • Stabilized liquid protein formulations in pharmaceutical containers
    Publication number: 20070092487
    Abstract: A container comprising a closure means coated by an inert fluorinated material and containing a liquid pharmaceutical composition. In particular, the container comprises a closure means coated by TEFLON and contains a HSA-free Interferon-? formulation having the following composition: 30 to 100 ?g/ml of interferon-?, an isotonicity agent, 0.1 to 2 mg/ml of Poloxamer 188, at least 0.12 mg/ml of L-Methionine and a buffer solution capable of maintaining the pH of the liquid formulation at a value between 3.0 and 4.0.
    Type: Application
    Filed: May 12, 2004
    Publication date: April 26, 2007
    Applicant: Ares Trading S.A.
    Inventors: Fabrizio Samaritani, Alessandra Del Rio
  • Human serum albumin-free stabilized interferon liquid formulations
    Publication number: 20070059285
    Abstract: A stabilized HSA-free liquid pharmaceutical composition is described, which comprises an interferon (IFN), wherein said formulation is a solution that comprises a buffer, a surfactant, an isotonicity agent and an antioxidant. Preferably the interferon is human recombinant IFN-beta.
    Type: Application
    Filed: April 29, 2004
    Publication date: March 15, 2007
    Applicant: Ares Trading S.A.
    Inventors: Fabrizio Samaritani, Alessandra Del Rio
  • Freeze-dried fsh/lh formulations
    Publication number: 20070059252
    Abstract: The invention relates to the field of pharmaceutical formulations of a mixture of follicle stimulating hormone (FSH) and luteinising hormone (LH), and to methods of producing such formulations.
    Type: Application
    Filed: June 16, 2004
    Publication date: March 15, 2007
    Applicant: Ares Trading S.A.
    Inventors: Fabrizio Samaritani, Piergiorgio Donati
  • Liquid formulations of tumor necrosis factor-binding proteins
    Publication number: 20070053906
    Abstract: The invention relates to a stable, pharmaceutically acceptable, aqueous formulation of TNF-binding protein, comprising a TNF-binding protein, a buffer and an isotonicity agent.
    Type: Application
    Filed: February 11, 2004
    Publication date: March 8, 2007
    Applicant: ARES TRADING S.A.
    Inventors: Fabrizio Samaritani, Alessandra Del Rio, Rita Agostinetto
  • Stabilized liquid protein formulations in pharmaceutical containers
    Patent number: RE43331
    Abstract: A container comprising a closure means coated by an inert fluorinated material and containing a liquid pharmaceutical composition. In particular, the container comprises a closure means coated by TEFLON (polytetrafluoruethylene (PTFE)) and contains a HSA-free Interferon-? formulation having the following composition: 30 to 100 ?g/ml of interferon-?, an isotonicity agent, 0.1 to 2 mg/ml of Poloxamer 188, at least 0.12 mg/ml of L-Methionine and a buffer solution capable of maintaining the pH of the liquid formulation at a value between 3.0 and 4.0.
    Type: Grant
    Filed: May 12, 2004
    Date of Patent: May 1, 2012
    Assignee: Ares Trading S.A.
    Inventors: Fabrizio Samaritani, Alessandra Del Rio